Posted inBiotechnology
In another reversal for rare disease field, FDA to reconsider Regenxbio gene therapy
In another sign that the FDA is easing its stance toward rare disease drug candidates under new leadership, the agency…
Posted inBiotechnology
Does Consuming Juice and Soda in Childhood Elevate the Risk of Developing High Blood Pressure?
A groundbreaking longitudinal study published in the American Heart Association’s journal Circulation reveals a significant association between the consumption of…
Posted inBiotechnology
New Gene-Network Method Highlights Over 600 Genes Linked to Schizophrenia
In a pioneering leap forward in psychiatric genetics, researchers at the Lieber Institute for Brain Development, in collaboration with an…
Posted inBiotechnology
Suppressing Ghost Noise in Single-Fiber Bidirectional Links
In the rapidly evolving landscape of optical fiber communications, the relentless pursuit of higher transmission capacities and more efficient infrastructures…
Posted inBiotechnology
Merck’s anti-TL1A antibody from Prometheus buyout passes ph. 3 test in ulcerative colitis
With pharma heavyweights clashing against one another and reeling in major sales in the ulcerative colitis (UC) arena, Merck is making advances…
Posted inBiotechnology
Microalgae-Powered Microbots Target Bladder Cancer
In a groundbreaking development poised to revolutionize bladder cancer therapy, researchers have engineered microscopic algae-based robots capable of delivering chemotherapy…
Posted inBiotechnology
AOC1 Controls Labor via Spermidine-Driven Autophagy
In a groundbreaking advancement that may revolutionize our understanding of human parturition, the 2026 study led by Chen, Long, Wang,…
Posted inBiotechnology
Microbial Inoculants: Boosting Sustainable Agroecosystem Health
Recent advances in microbiome science are reshaping our understanding of plant health, emphasizing the critical role of microbial communities living…
Posted inMedical Technology
Sanofi, Pangaea ink AI partnership deal to detect underdiagnosed genetic disease
French biopharma Sanofi has inked a partnership deal with Pangaea Data to use its AI platform that helps detect Alpha-1…
Posted inBiotechnology
AbbVie inks $10.9B Apogee buyout to bag hotly tipped eczema prospect
AbbVie has struck a deal to buy Apogee Therapeutics for $10.9 billion. The deal will give AbbVie control of a late-phase…